Riskpilot← Back to searchSign inGet full accessB3 FYSIO AS
ASActiveOrg 913221796Høgåsen 29, 5410 SagvågPhysiotherapy activities · NACE 8695Est. 20142 employees
Revenue 2024
NOK 2,6M
+1% vs 2023
EBITDA margin
0.2%
+140% vs 2023
Equity ratio
-170.5%
Financial strength
Net profit 2024
NOK -28K
-2% vs 2023
| Revenue | NOK 2,6M | +1% |
| EBITDA | NOK 5K | +140% |
| Net profit | NOK -28K | -2% |
| Total assets | NOK 179K | -15% |
| Equity | NOK -304K | -10% |
| Employees | 2 | — |
Legal name
B3 FYSIO AS
Org number
913221796
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
12. februar 2014
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Å drive fysioterapivirksomhet, veiledning og rådgivning, samt delta i andre selskaper og investere i eiendom og annet som er relatert til driften.
Address
Høgåsen 29, 5410 Sagvåg
Phone
+4747757772
Email
vegar@b3helse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 649 | 2 074 | 2 356 | 2 564 | 2 588 |
| Staff expenses | −893 | −1 488 | −1 603 | −1 887 | −1 814 |
| EBITDA | 114 | −248 | −21 | 2 | 5 |
| Depreciation & amort. | −0 | −3 | −6 | −6 | −6 |
| EBIT | 114 | −252 | −27 | −4 | −1 |
| Net financials | −0 | −1 | −18 | −23 | −27 |
| Profit before tax | 114 | −252 | −45 | −27 | −28 |
| Tax | 6 | −0 | −0 | −0 | −0 |
| Net profit | 107 | −252 | −45 | −27 | −28 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 210 | 43 | 30 | 210 | 179 |
| Equity | 48 | −205 | −250 | −277 | −304 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 162 | 247 | 279 | 487 | 483 |
| Total debt | 162 | 247 | 279 | 487 | 483 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
-170.5%
This company
38.2%
Market median
-546% vs market
20202024
Return on equity
-2768700.0%
This company
18.4%
Market median
-15047383% vs market
20202024
Net profit margin
-1.1%
This company
8.1%
Market median
-114% vs market
20202024
Asset turnover
14.49×
This company
1.12×
Market median
+1194% vs market
20202024
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of B3 FYSIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Rasmussen Lønnheim | Chief Executive Officer | 0 companies |
| Vegar Rasmussen Lønnheim | Chairman | 0 companies |